BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 15701583)

  • 1. New dosing strategies for antibacterial agents in the neonate.
    de Hoog M; Mouton JW; van den Anker JN
    Semin Fetal Neonatal Med; 2005 Apr; 10(2):185-94. PubMed ID: 15701583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of pharmacokinetics and pharmacodynamics: does the dose matter?
    MacGowan AP
    Clin Infect Dis; 2001 Sep; 33 Suppl 3():S238-9. PubMed ID: 11524725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal antibiotic dosing. The pharmacokinetic-pharmacodynamic interface.
    Reed MD
    Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):17-24. PubMed ID: 19667545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine.
    McKellar QA; Sanchez Bruni SF; Jones DG
    J Vet Pharmacol Ther; 2004 Dec; 27(6):503-14. PubMed ID: 15601444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of pharmacokinetics/pharmacodynamics of antibacterials in their dosing regimen selection.
    Scaglione F; Paraboni L
    Expert Rev Anti Infect Ther; 2006 Jun; 4(3):479-90. PubMed ID: 16771624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of once-daily dosing of aminoglycosides through Bayesian simulation.
    Garrelts JC
    Pharmacotherapy; 1996; 16(2):286-94. PubMed ID: 8820474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics: relation to antimicrobial resistance.
    Rybak MJ
    Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S38-45; discussion S64-73. PubMed ID: 16813981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selecting antibiotics based on pharmacokinetic and pharmacodynamic principles.
    Klutman NE
    Pharm Pract Manag Q; 1996 Jul; 16(2):9-12. PubMed ID: 10161616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the dose matter?
    Craig WA
    Clin Infect Dis; 2001 Sep; 33 Suppl 3():S233-7. PubMed ID: 11524724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents.
    Hyatt JM; McKinnon PS; Zimmer GS; Schentag JJ
    Clin Pharmacokinet; 1995 Feb; 28(2):143-60. PubMed ID: 7736689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetic effects of antibiotics on the development of bacterial resistance particularly in reference to azithromycin].
    Wenisch C
    Wien Med Wochenschr; 2000; 150(3):37-41. PubMed ID: 10756595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choosing an antibiotic on the basis of pharmacodynamics.
    Craig WA
    Ear Nose Throat J; 1998 Jun; 77(6 Suppl):7-11; discussion 11-2. PubMed ID: 9674328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of antibiotic dosing intervals from in vitro susceptibility, pharmacokinetics and post-antibiotic effect: theoretical considerations.
    Turnidge JD
    Scand J Infect Dis Suppl; 1990; 74():137-41. PubMed ID: 2097701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosing antibiotics in neonates: review of the pharmacokinetic data.
    Rivera-Chaparro ND; Cohen-Wolkowiez M; Greenberg RG
    Future Microbiol; 2017 Sep; 12(11):1001-1016. PubMed ID: 28758800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is combination therapy with betalactam plus aminoglycoside (AGL) improving the outcome of nosocomial meningitis in children?
    Ondrusova A; Grey E; Benca J; Rudinsky B; Huttova M; Bauer F; Kovac M; Sramka M
    Neuro Endocrinol Lett; 2007 Jun; 28 Suppl 2():17-8. PubMed ID: 17558368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentration-response relationships as a basis for choice of the optimal endpoints of the antimicrobial effect: daptomycin and vancomycin pharmacodynamics with staphylococci in an in vitro dynamic model.
    Smirnova MV; Lubenko IY; Portnoy YA; Zinner SH; Firsov AA
    Int J Antimicrob Agents; 2007 Feb; 29(2):165-9. PubMed ID: 17207607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding pharmacokinetics/pharmacodynamics in managing neonatal sepsis.
    Lutsar I; Metsvaht T
    Curr Opin Infect Dis; 2010 Jun; 23(3):201-7. PubMed ID: 20179595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic properties of meropenem.
    Nicolau DP
    Clin Infect Dis; 2008 Sep; 47 Suppl 1():S32-40. PubMed ID: 18713048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reappraisal of Contemporary Pharmacokinetic and Pharmacodynamic Principles for Informing Aminoglycoside Dosing.
    Bland CM; Pai MP; Lodise TP
    Pharmacotherapy; 2018 Dec; 38(12):1229-1238. PubMed ID: 30403305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrolides: pharmacokinetics and pharmacodynamics.
    Van Bambeke F; Tulkens PM
    Int J Antimicrob Agents; 2001; 18 Suppl 1():S17-23. PubMed ID: 11574190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.